Virginia Piper Cancer Institute — Minneapolis, Minnesota

Virginia Piper Cancer Institute is a clinical research site located in Minneapolis, Minnesota, United States 55407.

Crixeo Health Trust Score: 87/100 (GOOD). This profile has not yet been claimed by the site owner.

Virginia Piper Cancer Institute has participated in 64 clinical trials with 8 currently active.

Therapeutic areas: Intrahepatic Cholangiocarcinoma, Stage I Multiple Myeloma, Stage II Multiple Myeloma.

Sponsors: Allina Health System, National Cancer Institute (NCI), Alliance for Clinical Trials in Oncology.

Sponsor Feasibility Report

Trust Score: 87/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Virginia Piper Cancer Institute?

Virginia Piper Cancer Institute has a Crixeo Trust Score of 87/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Virginia Piper Cancer Institute conducted?

Virginia Piper Cancer Institute has 64 clinical trials on record, with 8 currently active. Their work covers Intrahepatic Cholangiocarcinoma, Stage I Multiple Myeloma, Stage II Multiple Myeloma.

Is Virginia Piper Cancer Institute accredited by Crixeo Health?

Yes — Virginia Piper Cancer Institute holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Virginia Piper Cancer Institute?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.